Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying

Arts, J.; Caenepeel, P.; Verbeke, K.; Tack, J.
April 2005
Gut;Apr2005, Vol. 54 Issue 4, p455
Academic Journal
Background and aims: Although delayed gastric emptying is considered a major pathophysiological mechanism in functional dyspepsia, the efficacy of prokinetic drugs has not been established. Recent studies using macrolide prokinetics were negative but receptor desensitisation may have played a role. The aim of the present study was to evaluate the influence on meal induced symptoms of acutely administered erythromycin in patients with gastroparesis. Methods: In 20 patients with functional dyspepsia, gastric emptying was studied twice using the 14C octanoic acid and 13C glycin breath test to establish the reproducibility of the test. Breath samples were taken before the meal and at 15 minute intervals for a period of 240 minutes postprandially. At each breath sampling, the patient was asked to grade the intensity (0-3) of six dyspeptic symptoms. Twenty four patients (three men, mean age 43.5 (3) years) with dyspeptic symptoms and delayed gastric emptying were studied twice after pretreatment with saline or erythromycin intravenously. Results: Meal related symptom severity scores were reproducible. Treatment with erythromycin significantly enhanced solid and liquid gastric emptying (t½ 146 (27) v 72 (7) minutes, respectively (p<0.01), and 87 (6) v 63 (5) minutes (p<0.001 )). Only the severity of bloating was significantly improved by erythromycin (23 (3.9) v 14.5 (2.7); p<0.01); all other symptoms and the cumulative meal related symptom score were not altered by erythromycin. Conclusions: In a setting where desensitisation played no role, erythromycin enhanced gastric emptying was not associated with a beneficial effect on meal related symptom severity.


Related Articles

  • Enhancing of erythromycin production bySaccharopolyspora erythraeawith common and uncommon oils. Hamedi, J.; Malekzadeh, F.; Saghafi-nia, A. // Journal of Industrial Microbiology & Biotechnology;Nov2004, Vol. 31 Issue 10, p447 

    The enhancing effect of various concentrations of 18 oils and a silicon antifoam agent on erythromycin production bySaccharopolyspora erythraeawas evaluated in a complex medium containing soybean flour and dextrin as the main substrates. The oils used consisted of sunflower, pistachio,...

  • Inactivation of Macrolides by Producers and Pathogens. Matsuoka, Mayumi; Sasaki, Tsuguo // Current Drug Targets - Infectious Disorders;Sep2004, Vol. 4 Issue 3, p217 

    Inactivation, one of the mechanisms of resistance to macrolide, lincosamide and streptogramin (MLS) antibiotics, appears to be fairly rare in clinical isolates in comparison with target site modification or efflux. However, inactivation is one of the major mechanisms through which...

  • Research brief: Azithromycin 'better' for pertussis.  // GP: General Practitioner;8/2/2004, p11 

    Canadian researchers compared treatment with azithromycin or erythromycin in 477 children aged six months to 16 years who had symptoms of pertussis or a positive culture. Both antibiotics successfully eradicated infection, but GI side-effects were reported more often and compliance with the full...

  • Benzamycin.  // Royal Society of Medicine: Medicines;2002, p106 

    The article presents information on benzamycin. The drug is a proprietary, prescription-only compound preparation of the antibacterial and (macrolide) antibiotic erythromycin and the keratolytic and antimicrobial benzoyl peroxide. It can be used to treat acne, and is available as a gel for...

  • Rommix.  // Royal Society of Medicine: Medicines;2002, p481 

    The article presents information on rommix, a proprietary, prescription-only preparation of the antibacterial and macrolide antibiotic erythromycin. The drug can be used in the treatment and prevention of many forms of infection. It is available as tablets and a liquid oral mixture.

  • Are newer macrolides effective in eradicating carriage of pertussis? Srinivasan, R.; Yeo, I. H. // Archives of Disease in Childhood;Mar2005, Vol. 90 Issue 3, p322 

    The article presents information on the effectiveness of newer macrolides in eradicating carriage of pertussis. Antimicrobials are usually administered when pertussis is suspected or confirmed. If the disease is already established, antibiotics have little or no effect on the clinical course of...

  • Antimicrobial Resistance among Campylobacter Strains, United States, 1997-2001. Gupta, Amita; Nelson, Jennifer M.; Barrett, Timothy J.; Tauxe, Robert V.; Rossiter, Shannon P.; Friedman, Cindy R.; Joyce, Kevin W.; Angulo, Frederick J.; Smith, Kirk E.; Jones, Timothy F.; Hawkins, Marguerite A.; Shiferaw, Beletshachew; Beebe, James L.; Vugia, Duc J.; Rabatsky-Ehr, Terry; Benson, James A.; Root, Timothy P. // Emerging Infectious Diseases;Jun2004, Vol. 10 Issue 6, p1102 

    We summarize antimicrobial resistance surveillance data in human and chicken isolates of Campylobacter. Isolates were from a sentinel county study from 1989 through 1990 and from nine state health departments participating in National Antimicrobial Resistance Monitoring System for enteric...

  • Treatment Options for Streptococcal Pharyngitis. Marcy, S. Michael // Clinical Pediatrics;May2007 Supplement, Vol. 46 Issue S4, p36S 

    Group A β-hemolytic streptococcus, the most common bacterial cause of pharyngitis, is susceptible to treatment with penicillins, macrolides, or cephalosporins. Current treatment guidelines recommend narrow-spectrum penicillins as first-choice therapy. Macrolides (erythromycin) and...

  • Significant Breakthroughs in Search for Anti-Infectious Agents Derived from Erythromycin A. Xiaodong Ma; Shutao Ma // Current Medicinal Chemistry;May2011, Vol. 18 Issue 13, p1993 

    No abstract available.


Read the Article


Sign out of this library

Other Topics